We are live on ! Find out more
PRDS

Pardes Biosciences, Inc. Common Stock
PRDS

Delisted

PRDS was delisted on the 30th of August, 2023.

Back to rankings

41 hedge funds and large institutions have $573M invested in Pardes Biosciences, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more funds holding in top 10

Funds holding in top 10: 1 → 7 (+6)

227% more capital invested

Capital invested by funds: $175M → $573M (+$397M)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

33% less funds holding

Funds holding: 61 → 41 (-20)

53% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 36

Holders
41
Holders Change
-20
Holders Change %
-32.79%
% of All Funds
0.63%
Holding in Top 10
7
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+600%
% of All Funds
0.11%
New
17
Increased
9
Reduced
10
Closed
36
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FCMV
Foresite Capital Management V
California
+$102M
2
FM
Frazier Management
Washington
+$28.6M
3
RCM
RA Capital Management
Massachusetts
+$24.7M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$18M
5
EC
EcoR1 Capital
California
+$14.3M

Top Sellers

Rank Fund Capital Flow
1
ACA
Arena Capital Advisors
California
-$9.98M
2
FCM
Farallon Capital Management
California
-$9.95M
3
PHS
PFM Health Sciences
California
-$7.43M
4
SRCM
Sage Rock Capital Management
New York
-$6.62M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$6.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
51
Marshall Wace
United Kingdom
– -$1.27M -127,202 Closed
CCM
52
Context Capital Management
California
– -$1.21M -121,797 Closed
Balyasny Asset Management
53
Balyasny Asset Management
Illinois
– -$1.19M -120,000 Closed
LOAMU
54
Lombard Odier Asset Management (USA)
New York
– -$995K -100,000 Closed
PMAM
55
Picton Mahoney Asset Management
Ontario, Canada
– -$995K -100,000 Closed
CH
56
CVI Holdings
Delaware
– -$992K -99,700 Closed
LC
57
Littlejohn & Co
Connecticut
– -$726K -72,925 Closed
DKCM
58
Davidson Kempner Capital Management
New York
– -$498K -50,000 Closed
Nomura Holdings
59
Nomura Holdings
Japan
– -$509K -50,000 Closed
PSAMP
60
P. Schoenfeld Asset Management (PSAM)
New York
– -$498K -50,000 Closed
MF
61
Magnetar Financial
Illinois
– -$487K -48,949 Closed
Susquehanna International Group
62
Susquehanna International Group
Pennsylvania
– -$440K -44,247 Closed
AA
63
AQR Arbitrage
Connecticut
– -$387K -38,900 Closed
SSA
64
Schonfeld Strategic Advisors
New York
– -$271K -27,209 Closed
DAM
65
Deltec Asset Management
New York
– -$249K -25,000 Closed
BI
66
Bulldog Investors
New Jersey
– -$199K -20,000 Closed
Walleye Trading
67
Walleye Trading
New York
– -$197K -19,757 Closed
WRBC
68
W.R. Berkley Corp
Connecticut
– -$196K -19,650 Closed
E
69
Ergoteles
New York
– -$186K -18,718 Closed
Walleye Capital
70
Walleye Capital
New York
– -$177 -17,772 Closed
MI
71
MMCAP International
Cayman Islands
– -$164K -16,530 Closed
Toronto Dominion Bank
72
Toronto Dominion Bank
Ontario, Canada
– -$119K -12,002 Closed
Calamos Advisors
73
Calamos Advisors
Illinois
– -$100K -10,000 Closed
DCM
74
Dupont Capital Management
Delaware
– -$100K -10,000 Closed
VI
75
Vestcor Inc
New Brunswick, Canada
– -$4K -400 Closed
1 2
3
4

PRDS Hedge Fund Activity: Q4 2021 in Review

41 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Pardes Biosciences, Inc. Common Stock (PRDS) for Q4 2021, worth a combined $573M — up 227% from $175M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of PRDS and 17 opened new positions — a net loss of 19 holders — while 10 trimmed existing stakes and 9 added.

The largest buyer was Foresite Capital Management V, adding an estimated $102M. The largest seller was Arena Capital Advisors, cutting an estimated $9.98M.

  • 41 institutional investors held Pardes Biosciences, Inc. Common Stock (PRDS) as of Q4 2021, down from 61 in Q3 2021.
  • Funds reported $573M of Pardes Biosciences, Inc. Common Stock stock for Q4 2021, up 227% quarter-over-quarter.
  • 17 funds opened new Pardes Biosciences, Inc. Common Stock positions in Q4 2021 and 36 closed out, a net change of -19 holders.
  • The largest Pardes Biosciences, Inc. Common Stock buyer in Q4 2021 was Foresite Capital Management V, an estimated $102M added.
  • The largest Pardes Biosciences, Inc. Common Stock seller in Q4 2021 was Arena Capital Advisors, an estimated $9.98M sold.

Based on aggregated 13F filings for Q4 2021.